Correlation Between Medigen Vaccine and PharmaEngine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Vaccine and PharmaEngine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Vaccine and PharmaEngine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Vaccine Biologics and PharmaEngine, you can compare the effects of market volatilities on Medigen Vaccine and PharmaEngine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Vaccine with a short position of PharmaEngine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Vaccine and PharmaEngine.

Diversification Opportunities for Medigen Vaccine and PharmaEngine

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Medigen and PharmaEngine is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Vaccine Biologics and PharmaEngine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmaEngine and Medigen Vaccine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Vaccine Biologics are associated (or correlated) with PharmaEngine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmaEngine has no effect on the direction of Medigen Vaccine i.e., Medigen Vaccine and PharmaEngine go up and down completely randomly.

Pair Corralation between Medigen Vaccine and PharmaEngine

Assuming the 90 days trading horizon Medigen Vaccine Biologics is expected to generate 1.46 times more return on investment than PharmaEngine. However, Medigen Vaccine is 1.46 times more volatile than PharmaEngine. It trades about 0.5 of its potential returns per unit of risk. PharmaEngine is currently generating about 0.07 per unit of risk. If you would invest  3,525  in Medigen Vaccine Biologics on November 3, 2024 and sell it today you would earn a total of  1,380  from holding Medigen Vaccine Biologics or generate 39.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medigen Vaccine Biologics  vs.  PharmaEngine

 Performance 
       Timeline  
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.
PharmaEngine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PharmaEngine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, PharmaEngine is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Medigen Vaccine and PharmaEngine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Vaccine and PharmaEngine

The main advantage of trading using opposite Medigen Vaccine and PharmaEngine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Vaccine position performs unexpectedly, PharmaEngine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaEngine will offset losses from the drop in PharmaEngine's long position.
The idea behind Medigen Vaccine Biologics and PharmaEngine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity